1.
Bioorg Med Chem Lett
; 21(12): 3818-22, 2011 Jun 15.
Artículo
en Inglés
| MEDLINE
| ID: mdl-21565500
RESUMEN
MK2 kinase is a promising drug discovery target for the treatment of inflammatory diseases. Here, we describe the discovery of novel MK2 inhibitors using X-ray crystallography and structure-based drug design. The lead has in vivo efficacy in a short-term preclinical model.